Loading candles…
Bal Pharma Ltd, incorporated in 1987, operates in the pharmaceutical industry with a focus on manufacturing and marketing active pharmaceutical ingredients (APIs), finished formulations, and specialty products. The company produces pharmaceutical products including APIs, generic drugs, specialty drugs, and finished formulations. Bal Pharma serves multiple therapeutic segments such as anti-diabetics, anti-infectives, and gastroenterology, catering to both domestic and international markets. The company concentrates on developing a pipeline of generic and specialty drugs while managing a diverse portfolio to address various healthcare needs globally.
| Results - FY25 |
| To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters |
| 29 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.